These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 155745)

  • 1. Renal impairment in urate excretion in patients with Down's syndrome.
    Nishida Y; Akaoka I; Kobayashi M; Maruki K; Oshima Y
    J Rheumatol; 1979; 6(1):103-7. PubMed ID: 155745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal serum immunoglobulin levels in Down's syndrome patients.
    Nishida Y; Sano Y; Akaoka I; Maruki M; Suzuki T; Maruki K
    Am J Ment Defic; 1978 Jul; 83(1):16-20. PubMed ID: 150229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of persons with Down's syndrome on two projective techniques.
    Brink M; Grundlingh EM
    Am J Ment Defic; 1976 Nov; 81(3):265-70. PubMed ID: 136898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte glucose-6 phosphate dehydrogenase (G6PD) and Australia antigen hepatitis in Down's syndrome.
    Sutnick AI; Oski FA; London WT; Millman I; Blumberg BS
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):3-8. PubMed ID: 4257700
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
    Hann HW; Deacon JC; London WT
    Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative mortality in mentally retarded patients in California, with and without Down's syndrome, 1986-1991.
    Singer RB; Strauss D
    J Insur Med; 1997; 29(3):172-84. PubMed ID: 10176367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of bio-clinical parameters and intelligence in subjects with Down's syndrome and other retardates.
    Klebba JT; Gershbein LL; Marks R
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):159-80. PubMed ID: 4277109
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and concentration of 5-phosphoribosyl-1-pyrophosphate in erythrocytes from patients with Down's syndrome.
    Nishida Y; Akaoka I; Nishizawa T; Maruki M; Maruki K
    Ann Rheum Dis; 1977 Jun; 36(3):261-3. PubMed ID: 141914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte adenosine deaminase, purine nucleoside phosphorylase and phosphoribosyltransferase activity in patients with Down's syndrome.
    Puukka R; Puukka M; Leppilampi M; Linna SL; Kouvalainen K
    Clin Chim Acta; 1982 Dec; 126(3):275-81. PubMed ID: 6217925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Uric acid and creatinine index in healthy subjects and in the mentally retarded].
    Stuber A; Paksi A
    Orv Hetil; 1976 Sep; 117(36):2167-9. PubMed ID: 967423
    [No Abstract]   [Full Text] [Related]  

  • 12. Uric acid and renal function in multiple sclerosis.
    Kanabrocki EL; Ryan MD; Hermida RC; Ayala DE; McCormick JB; Dawson S; Lojo L; Hoffman HS; Siegel G; Friedman N; Eladasori B; Parachuri R; Nemchausky BA
    Clin Ter; 2008; 159(1):35-40. PubMed ID: 18399261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output.
    Perez-Ruiz F; Calabozo M; Erauskin GG; Ruibal A; Herrero-Beites AM
    Arthritis Rheum; 2002 Dec; 47(6):610-3. PubMed ID: 12522834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis A and B in non-institutionalized mentally retarded patients.
    Renner F; Andrle M; Horak W; Rett A
    Hepatogastroenterology; 1985 Aug; 32(4):175-7. PubMed ID: 2932380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of the nucleus basalis in Down's syndrome.
    Casanova MF; Walker LC; Whitehouse PJ; Price DL
    Ann Neurol; 1985 Sep; 18(3):310-3. PubMed ID: 2932050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal use of nutritional supplements during the first month of pregnancy and decreased risk of Down's syndrome: case-control study.
    Czeizel AE; Puhó E
    Nutrition; 2005 Jun; 21(6):698-704; discussion 774. PubMed ID: 15925294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen metabolites and prooxidant status in children with Down's syndrome.
    Carratelli M; Porcaro L; Ruscica M; De Simone E; Bertelli AA; Corsi MM
    Int J Clin Pharmacol Res; 2001; 21(2):79-84. PubMed ID: 11824651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the mole fraction ratio of lactate dehydrogenase subunits in the lymphocytes of Down's syndrome patients].
    Tamarkina AD; Filippov IK; Annenkov GA; Beniashvili GKh
    Genetika; 1978 Feb; 14(2):354-8. PubMed ID: 150994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of some purine metabolizing enzymes in lymphocytes from patients with Down's syndrome.
    Puukka R; Puukka M; Perkkilä L; Kouvalainen K
    Biochem Med Metab Biol; 1986 Aug; 36(1):45-50. PubMed ID: 2943306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell glucose metabolism in Down's syndrome.
    Magnani M; Stocchi V; Novelli G; Dachà M; Fornaini G
    Clin Physiol Biochem; 1987; 5(1):9-14. PubMed ID: 2953518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.